Literature DB >> 33634147

Transcriptional and Proteomic Characterization of Telomere-Induced Senescence in a Human Alveolar Epithelial Cell Line.

Daniel I Sullivan1,2, Mao Jiang1,3, Angela M Hinchie1, Mark G Roth1, Harinath Bahudhanapati1,2, Mehdi Nouraie1,2, Jie Liu4,5,6, John F McDyer1, Rama K Mallampalli7, Yingze Zhang1,2, Daniel J Kass1,2, Toren Finkel4,5,6, Jonathan K Alder1,2.   

Abstract

Cellular senescence due to telomere dysfunction has been hypothesized to play a role in age-associated diseases including idiopathic pulmonary fibrosis (IPF). It has been postulated that paracrine mediators originating from senescent alveolar epithelia signal to surrounding mesenchymal cells and contribute to disease pathogenesis. However, murine models of telomere-induced alveolar epithelial senescence fail to display the canonical senescence-associated secretory phenotype (SASP) that is observed in senescent human cells. In an effort to understand human-specific responses to telomere dysfunction, we modeled telomere dysfunction-induced senescence in a human alveolar epithelial cell line. We hypothesized that this system would enable us to probe for differences in transcriptional and proteomic senescence pathways in vitro and to identify novel secreted protein (secretome) changes that potentially contribute to the pathogenesis of IPF. Following induction of telomere dysfunction, a robust senescence phenotype was observed. RNA-seq analysis of the senescent cells revealed the SASP and comparisons to previous murine data highlighted differences in response to telomere dysfunction. We conducted a proteomic analysis of the senescent cells using a novel biotin ligase capable of labeling secreted proteins. Candidate biomarkers selected from our transcriptional and secretome data were then evaluated in IPF and control patient plasma. Four novel proteins were found to be differentially expressed between the patient groups: stanniocalcin-1, contactin-1, tenascin C, and total inhibin. Our data show that human telomere-induced, alveolar epithelial senescence results in a transcriptional SASP that is distinct from that seen in analogous murine cells. Our findings suggest that studies in animal models should be carefully validated given the possibility of species-specific responses to telomere dysfunction. We also describe a pragmatic approach for the study of the consequences of telomere-induced alveolar epithelial cell senescence in humans.
Copyright © 2021 Sullivan, Jiang, Hinchie, Roth, Bahudhanapati, Nouraie, Liu, McDyer, Mallampalli, Zhang, Kass, Finkel and Alder.

Entities:  

Keywords:  A549; IPF; SASP; aging; biomarker; mass spectrometry; secretome; telomerase

Year:  2021        PMID: 33634147      PMCID: PMC7902064          DOI: 10.3389/fmed.2021.600626

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  58 in total

1.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

2.  An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis.

Authors:  Slavé Petrovski; Jamie L Todd; Michael T Durheim; Quanli Wang; Jason W Chien; Fran L Kelly; Courtney Frankel; Caroline M Mebane; Zhong Ren; Joshua Bridgers; Thomas J Urban; Colin D Malone; Ashley Finlen Copeland; Christie Brinkley; Andrew S Allen; Thomas O'Riordan; John G McHutchison; Scott M Palmer; David B Goldstein
Journal:  Am J Respir Crit Care Med       Date:  2017-07-01       Impact factor: 21.405

3.  S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.

Authors:  Atsuko Hara; Noriho Sakamoto; Yuji Ishimatsu; Tomoyuki Kakugawa; Shota Nakashima; Shintaro Hara; Misato Adachi; Hanako Fujita; Hiroshi Mukae; Shigeru Kohno
Journal:  Respir Med       Date:  2011-12-30       Impact factor: 3.415

4.  A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells.

Authors:  M Lieber; B Smith; A Szakal; W Nelson-Rees; G Todaro
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

5.  Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology.

Authors:  C Vancheri; M Failla; N Crimi; G Raghu
Journal:  Eur Respir J       Date:  2010-03       Impact factor: 16.671

Review 6.  Therapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agents.

Authors:  Hiroshi Tsutsumi; Tomohiro Tanaka; Nami Ohashi; Hiroyuki Masuno; Hirokazu Tamamura; Kenichi Hiramatsu; Takanobu Araki; Satoshi Ueda; Shinya Oishi; Nobutaka Fujii
Journal:  Biopolymers       Date:  2007       Impact factor: 2.505

7.  Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer.

Authors:  Nadia Nathan; Violaine Giraud; Clément Picard; Hilario Nunes; Florence Dastot-Le Moal; Bruno Copin; Laurie Galeron; Alice De Ligniville; Nathalie Kuziner; Martine Reynaud-Gaubert; Dominique Valeyre; Louis-Jean Couderc; Thierry Chinet; Raphaël Borie; Bruno Crestani; Maud Simansour; Valérie Nau; Sylvie Tissier; Philippe Duquesnoy; Lamisse Mansour-Hendili; Marie Legendre; Caroline Kannengiesser; Aurore Coulomb-L'Hermine; Laurent Gouya; Serge Amselem; Annick Clement
Journal:  Hum Mol Genet       Date:  2016-01-19       Impact factor: 6.150

8.  Loss-of-function mutations in the RNA biogenesis factor NAF1 predispose to pulmonary fibrosis-emphysema.

Authors:  Susan E Stanley; Dustin L Gable; Christa L Wagner; Thomas M Carlile; Vidya Sagar Hanumanthu; Joshua D Podlevsky; Sara E Khalil; Amy E DeZern; Maria F Rojas-Duran; Carolyn D Applegate; Jonathan K Alder; Erin M Parry; Wendy V Gilbert; Mary Armanios
Journal:  Sci Transl Med       Date:  2016-08-10       Impact factor: 17.956

Review 9.  The epithelium in idiopathic pulmonary fibrosis: breaking the barrier.

Authors:  Ana Camelo; Rebecca Dunmore; Matthew A Sleeman; Deborah L Clarke
Journal:  Front Pharmacol       Date:  2014-01-10       Impact factor: 5.810

10.  Mitochondria as target to inhibit proliferation and induce apoptosis of cancer cells: the effects of doxycycline and gemcitabine.

Authors:  Sas N Dijk; Margherita Protasoni; Marilena Elpidorou; Albert M Kroon; Jan-Willem Taanman
Journal:  Sci Rep       Date:  2020-03-09       Impact factor: 4.379

View more
  3 in total

1.  The lysosomal proteome of senescent cells contributes to the senescence secretome.

Authors:  Miguel Rovira; Rebecca Sereda; David Pladevall-Morera; Valentina Ramponi; Ines Marin; Mate Maus; Julio Madrigal-Matute; Antonio Díaz; Fernando García; Javier Muñoz; Ana María Cuervo; Manuel Serrano
Journal:  Aging Cell       Date:  2022-09-10       Impact factor: 11.005

Review 2.  Insights into the Pathogenesis of Pulmonary Fibrosis from Genetic Diseases.

Authors:  Joanna Y Wang; Lisa R Young
Journal:  Am J Respir Cell Mol Biol       Date:  2022-07       Impact factor: 7.748

3.  Effect of Hypoxia in the Transcriptomic Profile of Lung Fibroblasts from Idiopathic Pulmonary Fibrosis.

Authors:  Yair Romero; Yalbi Itzel Balderas-Martínez; Miguel Angel Vargas-Morales; Manuel Castillejos-López; Joel Armando Vázquez-Pérez; Jazmín Calyeca; Luz María Torres-Espíndola; Nelly Patiño; Angel Camarena; Ángeles Carlos-Reyes; Edgar Flores-Soto; Guadalupe León-Reyes; Martha Patricia Sierra-Vargas; Iliana Herrera; Erika Rubí Luis-García; Víctor Ruiz; Rafael Velázquez-Cruz; Arnoldo Aquino-Gálvez
Journal:  Cells       Date:  2022-09-27       Impact factor: 7.666

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.